Employers who are wary of paying for workers' pricey weight-loss drugs are discovering a workaround: Offer coverage through a ...

Memphis researchers leading the way in learning more about weight loss and cancer.

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

The FDA rejected a Disc Medicine therapy for a rare blood disorder, the first experimental drug to go through a new program ...

CVS eMed partner GLP-1 offers employers a subsidized model for weight loss drugs with telehealth support and personalized care.

Insurers cite unsustainable costs as GLP-1 benefits disappear, accelerating a national shift in employer-sponsored ...

Bunnie Xo shared that in December 2025, she underwent “a bout of suicidal ideation” while taking a GLP-1.

A new review finds no convincing evidence that drugs like Ozempic raise people's risk of common thyroid cancers.

The U.S. Food and Drug Administration (FDA) plans to take steps to limit the use of GLP-1 in non-FDA-approved compounded ...

One researcher found patients on the weight loss drugs may not be getting enough essential vitamins and nutrients.

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions. This is a stunning gut-brain breakthrough.

Following functional endoscopic sinus surgery, adults with chronic rhinosinusitis with nasal polyps and obesity had a lower risk for revision surgery if they were prescribed a GLP-1 receptor agonist, ...